BSE · KPL.BO
Kwality Pharmaceuticals Limited
₹3,589.85-₹91.10 (-2.47%)
Kwality Pharmaceuticals Limited’s quoted price sits in the upper half of its reported 52-week range, 7.16% below the high.
Loading market information…
NSE · SASTASUNDR.NS · INR
Stock price, dividends, earnings
Quote as of Apr 29, 2026, 09:59 AM UTC. Cached market data; not a live quote.
One-year closing-price history · INR. Historical prices are not a forecast.
Sastasundar Ventures Limited’s quoted price sits in the lower half of its reported 52-week range, 22.15% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Sastasundar Ventures Limited’s forward annual dividend is ₹1.00 per share, paid annual. The forward yield is 0.35% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Sastasundar Ventures Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Established in 1989 and headquartered in Kolkata, India, Sastasundar Ventures Limited manages a comprehensive digital healthcare ecosystem across the country. In addition to its core healthcare activities, the company provides a variety of financial services, including loan financing, investments in shares and other securities, financial advisory, wealth management, and distribution. It also runs online portals such as sastasundar.com and retailershakti.com for the promotion of healthcare products and pathology services. Furthermore, Sastasundar offers crucial diagnostic services, encompassing both pathological and radiological investigations. Its business also extends to distributing pharmaceuticals and wellness items, delivering personalized health supplements, offering diet counseling, and providing health information. The company adopted its current name, Sastasundar Ventures Limited, in November 2016, having previously operated as Microsec Financial Services Limited.
Latest available per-share figures in INR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 06:22 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| ₹2.63B |
| Q4 2024 | May 28, 2024 | ₹5.17 | ₹2.97B |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₹3,589.85-₹91.10 (-2.47%)
Kwality Pharmaceuticals Limited’s quoted price sits in the upper half of its reported 52-week range, 7.16% below the high.
₹1,389.90-₹60.70 (-4.18%)
Fredun Pharmaceuticals Limited’s quoted price sits in the upper half of its reported 52-week range, 16.59% below the high.
₹2,585.10-₹27.70 (-1.06%)
NGL Fine-Chem Limited’s quoted price sits in the upper half of its reported 52-week range, 28.23% below the high.
₹2,081.80+₹171.65 (+8.99%)
Bharat Parenterals Limited’s quoted price sits in the upper half of its reported 52-week range, 9.18% below the high.
₹35.67-₹1.28 (-3.46%)
Sudarshan Pharma Industries Ltd.’s quoted price sits in the upper half of its reported 52-week range, 16.64% below the high.
₹86.78+₹7.04 (+8.83%)
Anuh Pharma Limited’s quoted price sits in the upper half of its reported 52-week range, 12.78% below the high.
₹148.90-₹1.36 (-0.91%)
Max India Limited’s quoted price sits in the lower half of its reported 52-week range, 32.32% below the high.
₹179.41-₹2.52 (-1.39%)
Wanbury Limited’s quoted price sits in the lower half of its reported 52-week range, 49.89% below the high.
